PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 20240 citations

Table S5 from Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.

View Full Paper
JTJoseph TokerJIJ. Bryan IorgulescuALAlexander Ling

Key Points

Key points are not available for this paper at this time.

Abstract

LncRNA transcriptome analysis in glioblastoma (GSE121810)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Toker et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522edehttps://doi.org/10.1158/1078-0432.27030847.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Table S5 from Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.2024
  2. 2Table S7 from Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.2024
  3. 3Table S7 from Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.2024
  4. 4Table S6 from Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.2024
  5. 5Table S1 from Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.2024